Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is a form of leukodystrophy that is characterized by infantile-onset macrocephaly, often with mild neurologic signs at presentation (such as mild motor delay), which worsen with time, leading to poor ambulation, falls, ataxia, spasticity, increasing seizures and cognitive decline. Brain magnetic resonance imaging reveals diffusely abnormal and mildly swollen white matter as well as subcortical cysts in the anterior temporal and frontoparietal regions.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
22 publications have been identified in PubMed for megalencephalic leukoencephalopathy with subcortical cysts. Research spans Basic Science / Preclinical (45%), Case Report / Case Series (32%), and Epidemiology / Natural History (9%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 10 |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 3:33 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Patient case studies | 7 | 32% |
Disease patterns and progression | 2 | 9% |
Research summaries | 1 | 5% |
Clinical study results | 1 | 5% |
New treatment approaches | 1 | 5% |
Potru M (2026). [PMID: 42037900](https://pubmed.ncbi.nlm.nih.gov/42037900/). *Cureus*. [Case Report / Case Series]
Lanciotti A (2026). [PMID: 41371307](https://pubmed.ncbi.nlm.nih.gov/41371307/). *Neurobiol Dis*. [Basic Science / Preclinical]
Pont-Espinós G (2026). [PMID: 41314544](https://pubmed.ncbi.nlm.nih.gov/41314544/). *J Biol Chem*. [Basic Science / Preclinical]
Sabbagh Q (2026). [PMID: 42063611](https://pubmed.ncbi.nlm.nih.gov/42063611/). *Neurol Genet*. [Basic Science / Preclinical]
Kerst S (2026). [PMID: 41654199](https://pubmed.ncbi.nlm.nih.gov/41654199/). *Neurobiol Dis*. [Basic Science / Preclinical]
Versaevel NRA (2026). [PMID: 42025183](https://pubmed.ncbi.nlm.nih.gov/42025183/). *Neuropediatrics*. [Clinical Trial Publication]
Sharma S (2026). [PMID: 41888865](https://pubmed.ncbi.nlm.nih.gov/41888865/). *Orphanet J Rare Dis*. [Basic Science / Preclinical]
Sartorelli J (2026). [PMID: 41483250](https://pubmed.ncbi.nlm.nih.gov/41483250/). *Neurol Sci*. [Epidemiology / Natural History]
Bisseling Q (2026). [PMID: 41331492](https://pubmed.ncbi.nlm.nih.gov/41331492/). *Glia*. [Basic Science / Preclinical]
Sharma S (2025). [PMID: 39829899](https://pubmed.ncbi.nlm.nih.gov/39829899/). *bioRxiv*. [Basic Science / Preclinical]